Search Prime Contracts

75N95022P00510

Purchase Order

Overview

Government Description
IN VITRO AND IN VIVO STUDY OF ROC-325 AND ITS ANALOGS IN LIVE SARS-COV-2 MODELS
Awardee
Texas Biomedical Research Institute
Awarding Agency
National Institute on Drug Abuse (NIDA) [HHS - NIH]
Funding Agency
National Center for Advancing Translational Sciences (NCATS) [HHS - NIH]
NAICS
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
PSC
Q301 - Reference Laboratory Testing
Place of Performance
San Antonio, TX 78227 United States
Pricing
Fixed Price
Set Aside
None
Extent Competed
Not Competed
Est. Average FTE
<1
Related Opportunity
In vitro and in vivo study of ROC-325 and its analogs in live SARS-CoV-2 models in support of COVID 19 research. (75N95022Q00477)
Analysis Notes
Amendment Since initial award the Potential End Date has been extended from 08/31/23 to 08/31/24 and the Potential Award value has increased from $99,990 to $99,991.
Sole Source This Purchase Order was awarded sole source to Texas Biomedical Research Institute because the government believes that only one company can provide the product / service (FAR 6.302-1).
Texas Biomedical Research Institute was awarded Purchase Order 75N95022P00510 (75N950-22-P-00510) for In Vitro And In Vivo Study Of Roc-325 And Its Analogs In Live Sars-Cov-2 Models worth up to $99,991 by National Center for Advancing Translational Sciences in August 2022. The contract has a duration of 2 years and was awarded through solicitation In vitro and in vivo study of ROC-325 and its analogs in live SARS-CoV-2 models in support of COVID 19 research. full & open with NAICS 541714 and PSC Q301 via sole source acquisition procedures with 1 bid received.

Status
(Complete)

Last Modified 8/31/23
Period of Performance
8/30/22
Start Date
8/31/24
Current End Date
8/31/24
Potential End Date
100% Complete

Obligations
$100.0K
Total Obligated
$100.0K
Current Award
$100.0K
Potential Award
100% Funded

Award Hierarchy

Purchase Order

75N95022P00510

Subcontracts

0

Activity Timeline

Interactive chart of timeline of amendments to 75N95022P00510

Opportunity Lifecycle

Procurement history for 75N95022P00510

Transaction History

Modifications to 75N95022P00510

People

Suggested agency contacts for 75N95022P00510

Competition

Number of Bidders
1
Solicitation Procedures
Sole Source
Other Than Full and Open Competition
Only One Source - Other
Evaluated Preference
None
Commercial Item Acquisition
Commercial Item
Simplified Procedures for Commercial Items
No

Other Categorizations

Subcontracting Plan
Plan Not Required
Cost Accounting Standards
Exempt
Business Size Determination
Large Business
Awardee UEI
J4EYPCJDQ1H6
Awardee CAGE
02MD3
Agency Detail
Awarding Office
75N950 NATIONAL INSTITUTES OF HEALTH NIDA
Funding Office
75N95C
Created By
hhssshifaraw
Last Modified By
hhssshifaraw
Approved By
hhssshifaraw

Legislative

Legislative Mandates
None Applicable
Performance District
TX-20
Senators
John Cornyn
Ted Cruz
Representative
Joaquin Castro

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
National Center for Advancing Translational Sciences, National Institutes of Health, Health and Human Services (075-0875) Health research and training Advisory and assistance services (25.1) $99,991 100%
Modified: 8/31/23